Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pertussis toxin attenuates experimental autoimmune encephalomyelitis by upregulating neuronal vascular endothelial growth factor.
Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience.
Antigen microarrays identify CNS-produced autoantibodies in RRMS.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Active Suppression Induced by Repetitive Self-Epitopes Protects against EAE Development.
Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II).
Effect of axotomy and 17β-estradiol on P2X7 receptor expression pattern in the hypoglossal nucleus of ovariectomized mice.
Clinical and demographic factors affecting disease severity in patients with multiple sclerosis.
Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS).
The Increasing Prevalence of Multiple Sclerosis in New Zealand.
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.
Uric acid: a potential biomarker of multiple sclerosis and of its disability.
Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium.
Considerations for subgroups and phenocopies in complex disease genetics.
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: No.
Non-protein amino acids and neurodegeneration: The enemy within.
A case-control study of dietary salt intake in pediatric-onset multiple sclerosis.
A novel stop mutation in the EDNRB gene in a family with Hirschsprung's disease associated with Multiple Sclerosis.
Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosis.
A case of demyelinating polyneuropathy associated with anti-myelin-associated glycoprotein antibodies with progressive quadriparesis and respiratory failure.
[Clinical course and prognosis of multiple sclerosis].
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases.
Effect of ether glycerol lipids on interleukin-1β release and experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
598
599
600
601
602
603
604
605
606
…
next ›
last »